Skip to main content
. 2016 Sep 27;3(1):28–36. doi: 10.1093/ehjcvp/pvw031

Figure 5.

Figure 5

Risk of major or CRNM bleeding for dabigatran, rivaroxaban, and apixaban compared with warfarin in the subgroup of patients ≥75 years. Crude IR for first bleeding episode are given as events per 100 person-years. CI, confidence interval; CRNM, clinically relevant non-major bleeding; HR, adjusted hazard ratio; IR, incidence rate; OAC, oral anticoagulant.